198 related articles for article (PubMed ID: 24582700)
1. Vitamin D deficiency is associated with mortality and adverse vascular access outcomes in patients with end-stage renal disease.
Walker JP; Hiramoto JS; Gasper WJ; Auyang P; Conte MS; Rapp JH; Lovett DH; Owens CD
J Vasc Surg; 2014 Jul; 60(1):176-83. PubMed ID: 24582700
[TBL] [Abstract][Full Text] [Related]
2. The association of mineral metabolism with vascular access patency.
Rosenberg JE; Astor BC; Deluca HF; Yevzlin AS
J Vasc Access; 2016 Sep; 17(5):392-396. PubMed ID: 27470251
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D deficiency--prognostic marker or mortality risk factor in end stage renal disease patients with diabetes mellitus treated with hemodialysis--a prospective multicenter study.
Schiller A; Gadalean F; Schiller O; Timar R; Bob F; Munteanu M; Stoian D; Mihaescu A; Timar B
PLoS One; 2015; 10(5):e0126586. PubMed ID: 25965403
[TBL] [Abstract][Full Text] [Related]
4. Incidence and risk factors of sepsis in hemodialysis patients in the United States.
Locham S; Naazie I; Canner J; Siracuse J; Al-Nouri O; Malas M
J Vasc Surg; 2021 Mar; 73(3):1016-1021.e3. PubMed ID: 32707386
[TBL] [Abstract][Full Text] [Related]
5. Age-related outcomes of arteriovenous grafts for hemodialysis access.
Arhuidese IJ; Beaulieu RJ; Aridi HD; Locham S; Baldwin EK; Malas MB
J Vasc Surg; 2020 Aug; 72(2):643-650. PubMed ID: 32067881
[TBL] [Abstract][Full Text] [Related]
6. Utilization, patency, and complications associated with vascular access for hemodialysis in the United States.
Arhuidese IJ; Orandi BJ; Nejim B; Malas M
J Vasc Surg; 2018 Oct; 68(4):1166-1174. PubMed ID: 30244924
[TBL] [Abstract][Full Text] [Related]
7. A comparison of patency and interventions in thigh versus Hemodialysis Reliable Outflow grafts for chronic hemodialysis vascular access.
Brownie ER; Kensinger CD; Feurer ID; Moore DE; Shaffer D
J Vasc Surg; 2016 Nov; 64(5):1392-1399. PubMed ID: 27444362
[TBL] [Abstract][Full Text] [Related]
8. Prediction of graft patency and mortality after distal revascularization and interval ligation for hemodialysis access-related hand ischemia.
Scali ST; Chang CK; Raghinaru D; Daniels MJ; Beck AW; Feezor RJ; Berceli SA; Huber TS
J Vasc Surg; 2013 Feb; 57(2):451-8. PubMed ID: 23244784
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D deficiency, mortality, and hospitalization in hemodialysis patients with or without protein-energy wasting.
Fiedler R; Dorligjav O; Seibert E; Ulrich C; Markau S; Girndt M
Nephron Clin Pract; 2011; 119(3):c220-6. PubMed ID: 21832848
[TBL] [Abstract][Full Text] [Related]
10. Patients with lower extremity dialysis access have poor primary patency and survival.
Pike SL; Farber A; Arinze N; Levin S; Cheng TW; Jones DW; Tan TW; Malas M; Rybin D; Siracuse JJ
J Vasc Surg; 2019 Dec; 70(6):1913-1918. PubMed ID: 31147128
[TBL] [Abstract][Full Text] [Related]
11. Hemodialysis vascular access and clinical outcomes: an observational multicenter study.
Soleymanian T; Sheikh V; Tareh F; Argani H; Ossareh S
J Vasc Access; 2017 Jan; 18(1):35-42. PubMed ID: 27791255
[TBL] [Abstract][Full Text] [Related]
12. Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial.
Jamison RL; Hartigan P; Kaufman JS; Goldfarb DS; Warren SR; Guarino PD; Gaziano JM;
JAMA; 2007 Sep; 298(10):1163-70. PubMed ID: 17848650
[TBL] [Abstract][Full Text] [Related]
13. Evidence for persistent vitamin D 1-alpha-hydroxylation in hemodialysis patients: evolution of serum 1,25-dihydroxycholecalciferol after 6 months of 25-hydroxycholecalciferol treatment.
Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
Nephron Clin Pract; 2008; 110(1):c58-65. PubMed ID: 18724068
[TBL] [Abstract][Full Text] [Related]
14. Influence of vascular access type on sex and ethnicity-related mortality in hemodialysis-dependent patients.
Woo K; Yao J; Selevan D; Hye RJ
Perm J; 2012; 16(2):4-9. PubMed ID: 22745609
[TBL] [Abstract][Full Text] [Related]
15. Vascular access outcomes and medication use: a USRDS study.
Yevzlin AS; Conley EL; Sanchez RJ; Young HN; Becker BN
Semin Dial; 2006; 19(6):535-9. PubMed ID: 17150056
[TBL] [Abstract][Full Text] [Related]
16. Bovine carotid artery biologic graft outperforms expanded polytetrafluoroethylene for hemodialysis access.
Arhuidese I; Reifsnyder T; Islam T; Karim O; Nejim B; Obeid T; Qazi U; Malas M
J Vasc Surg; 2017 Mar; 65(3):775-782. PubMed ID: 28236920
[TBL] [Abstract][Full Text] [Related]
17. Gender-Based Utilization and Outcomes of Autogenous Fistulas and Prosthetic Grafts for Hemodialysis Access.
Arhuidese IJ; Faateh M; Meshkin RS; Calero A; Shames M; Malas MB
Ann Vasc Surg; 2020 May; 65():196-205. PubMed ID: 31626935
[TBL] [Abstract][Full Text] [Related]
18. Effect of statins on survival in patients undergoing dialysis access for end-stage renal disease.
De Rango P; Parente B; Farchioni L; Cieri E; Fiorucci B; Pelliccia S; Manzone A; Simonte G; Lenti M
Semin Vasc Surg; 2016 Dec; 29(4):198-205. PubMed ID: 28779787
[TBL] [Abstract][Full Text] [Related]
19. Conversion of vascular access type among incident hemodialysis patients: description and association with mortality.
Bradbury BD; Chen F; Furniss A; Pisoni RL; Keen M; Mapes D; Krishnan M
Am J Kidney Dis; 2009 May; 53(5):804-14. PubMed ID: 19268411
[TBL] [Abstract][Full Text] [Related]
20. Patients started on hemodialysis with tunneled dialysis catheter have similar survival after arteriovenous fistula and arteriovenous graft creation.
Yuo TH; Chaer RA; Dillavou ED; Leers SA; Makaroun MS
J Vasc Surg; 2015 Dec; 62(6):1590-7.e2. PubMed ID: 26372193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
